Our findings indicated, in fact, that nearly 25% of our sample displayed a relevant depressive symptomatology according to BDI-II cutoff scores. Similar rates of depressive symptoms were reported by cross-sectional studies conducted among the general population of worst-hit countries during the initial stage of the pandemic [28,29]. Of note, the majority of individuals in our sample reported no depressive symptomatology. This might be due to the still relatively short exposure to the pandemic or to possible interindividual protective factors promoting mental health [30,31]. Our results also suggested that women and younger individuals were, to a certain degree, more likely to experience significant symptoms of depression in response to the COVID-19 outbreak. These findings may in part be due to the fact that women represent a greater percentage of the workforce that has been negatively affected by the COVID-19 outbreak, including retail, service industry, and healthcare, in addition to biological factors. Similarly, work loss and unpredictability that derived from the COVID-19 pandemic may be particularly stressful among younger age groups [15].